Title:
SENSITIVE SUBSTANCE ENCAPSULATION
Document Type and Number:
WIPO Patent Application WO/2001/045835
Kind Code:
A1
Abstract:
A process for stabilizing a sensitive substance; (a) plating a sensitive substance onto a solid carrier under a controlled atmosphere to reduce loss of the sensitive substance; (b) encapsulating the plated material under controlled atmosphere and airflow to reduce volatilization during the process and stabilize the sensitive substance.
Inventors:
PACIFICO CARL J (US)
WU WEN-HSIN (US)
FRALEY MARTA (US)
WU WEN-HSIN (US)
FRALEY MARTA (US)
Application Number:
PCT/US2000/033673
Publication Date:
June 28, 2001
Filing Date:
December 13, 2000
Export Citation:
Assignee:
BALCHEM CORP (US)
PACIFICO CARL J (US)
WU WEN HSIN (US)
FRALEY MARTA (US)
PACIFICO CARL J (US)
WU WEN HSIN (US)
FRALEY MARTA (US)
International Classes:
A23L1/00; A23L27/00; A23L27/12; A23L29/00; A61K9/50; A61K35/74; A61K38/43; B01J2/00; B01J13/02; (IPC1-7): B01J13/02; A23L1/22; A23P1/04; C12N11/12; C12N11/14
Domestic Patent References:
WO1996009773A1 | 1996-04-04 |
Foreign References:
GB825480A | 1959-12-16 | |||
GB1318799A | 1973-05-31 |
Other References:
PATENT ABSTRACTS OF JAPAN vol. 004, no. 054 (C - 008) 23 April 1980 (1980-04-23)
See also references of EP 1242174A1
See also references of EP 1242174A1
Attorney, Agent or Firm:
Baron, Ronald J. (NY, US)
Download PDF:
Claims:
WHAT IS CLAIMED IS:
1. | A method of encapsulating a sensitive material comprising: plating the sensitive material onto a solid carrier, in an atmosphere inert to the sensitive material, to form a plated material; and encapsulating the plated material. |
2. | The method of claim 1 wherein the atmosphere inert to the sensitive material is nitrogen, carbon dioxide, or helium. |
3. | The method of claim 1 wherein the solid carrier is chilled prior to plating with the sensitive material. |
4. | The method of claim 3 wherein the solid carrier is chilled by liquid nitrogen. |
5. | The method of claim 1 wherein the solid carrier is porous or semi porous. |
6. | The method of claim 5 wherein the solid carrier is maltodextrin, silicon dioxide, starches and starch derivatives, gums, or hydrocolloids. |
7. | The method of claim 6 wherein the encapsulation occurs in an atmosphere inert to the sensitive material. |
8. | The method of claim 7 wherein the atmosphere inert to the sensitive material is oxygenfree. |
9. | The method of claim 7 wherein the atmosphere inert to the sensitive material is nitrogen, carbon dioxide, or helium. |
10. | The method of claim 1 wherein the sensitive material has a boiling point of between about 40°F and 250°F. |
11. | The method of claim 1 wherein the atmosphere inert to the sensitive material is oxygenfree. |
12. | The method of claim 1 wherein the sensitive material is sprayed onto the solid carrier. |
13. | The method of claim 1 further comprising encapsulating the plated material with a melted encapsulant. |
14. | The method of claim 1 wherein the percentage of encapsulant in the resulting encapsulated particles is between about 10 to about 90%,. |
15. | The method of claim 14 wherein the percentage of encapsulant in the resulting encapsulated particles is between about 20 to about 80%. |
16. | The method of claim 1 wherein the sensitive material is a volatile material. |
17. | The method of claim 1 wherein the sensitive material is an oxygen sensitive material. |
18. | The method of claim 1 wherein the sensitive material is a biologically active substance. |
19. | The method of claim 18 wherein the biologically active substance is selected from the group consisting of Lactobacilli, Bifidobacterium, Enterococci, phytase, amylases, lipases, invertases, transglutaminases, proteases, lipoxygenases and pentosanases. |
20. | The method of claim 1 wherein the sensitive material is at least one selected from the group consisting of alcohols, acetones, ketones, aldehydes, organic acids, and antioxidants. |
Previous Patent: DISTRIBUTION OF GAS AND LIQUID IN A CONTACT DEVICE
Next Patent: MOLECULES DERIVED FROM MECHANISM BASED DRUG DESIGN
Next Patent: MOLECULES DERIVED FROM MECHANISM BASED DRUG DESIGN